Tag Archives: heathcare

Conference on Clinical Research for Rare Diseases on November 3rd


BIO members may be interested in the upcoming Conference on Clinical Research for Rare Diseases, hosted by the Rare Diseases Clinical Research Network.  The Rare Diseases Clinical Research Network is an initiative of the Office of Rare Diseases Research, NCATS, funded through a collaboration between NCATS and the NIH.  The conference will be held on November 3, 2016 at the Washington Marriott Wardman Park. There are more than 6,800 diseases classified as “rare” (defined as Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Tony Coelho: A Patient Advocate’s Perspective on Paying for Value


Yesterday, Health Affairs published an op-ed by Tony Coelho, Former Member of the U.S. House of Representatives and Chairman of the Partnership to improve patient care, on the benefit of patient-centered outcomes research to better inform medical care, without limiting patients’ and providers’ choices. As Coelho writes, ‘The movement to place greater financial risk on providers in an effort to pay for value rather than volume will have the effect of fundamentally changing the way Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Responds to GPhA Citizen Petition on Biosimilars Naming


Last September, the Generic Pharmaceutical Association (GPhA) filed a Citizen Petition with the FDA, requesting the FDA to “implement its INN naming policy equally to all biologics” and to require “all biologics approved under the Section 351(k) pathway…share the same INN [International Nonproprietary Name] as the RPP [reference protein product]” (the GPhA Petition). Today, BIO submitted our response. Contrary to the GPhA Petition, BIO believes that the legal, regulatory, and scientific principles related to biologics and biosimilarity Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,